New COVID-19 vaccine candidate leveraging nanotechnology is ‘promising’

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health, who have developed the nanotechnology based vaccine, say it has shown strong efficacy in preclinical disease models.